ImmuCell Corporation

5.35-0.0700-1.29%Vol 153 3441Y Perf -34.41%
Jan 27th, 2020 16:00
BID5.35 ASK5.40
Open5.70 Previous Close5.42
Pre-Market5.60 After-Market-
 0.18 3.32%  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★     57.64
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★+     49.97
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap (M)39 
Earnings Rating
Neutral
Price Range Ratio 52W %
18.16 
Earnings Date
18th Feb 2020

Today's Price Range

5.235.75

52W Range

4.708.28

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
9.27%
1 Month
6.69%
3 Months
4.23%
6 Months
-11.87%
1 Year
-34.41%
3 Years
-9.36%
5 Years
-16.61%
10 Years
29.05%

TickerPriceChg.Chg.%
ICCC5.35-0.0700-1.29
AAPL308.95-9.3600-2.94
GOOG1 433.90-32.8100-2.24
MSFT162.28-2.7600-1.67
XOM64.72-1.6000-2.41
WFC47.09-0.4800-1.01
JNJ148.750.43000.29
FB214.87-3.0700-1.41
GE11.44-0.2700-2.31
JPM132.03-1.1200-0.84
Earnings HistoryEstimateReportedSurprise %
Q02 2016-0.00-
Q01 2016-0.11-
Q04 2015-0.09-
Q03 2015-0.11-
Q02 2015-0.03-
Q01 2015-0.15-
Q04 2014-0.04-
Q03 2014-0.00-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date18th Feb 2020
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume153 344
Shares Outstanding (K)7 210
Trades Count64
Dollar Volume56 035
Avg. Volume204 830
Avg. Weekly Volume641 478
Avg. Monthly Volume169 314
Avg. Quarterly Volume63 164
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The firm has developed products that provide immediate immunity to newborn dairy and beef cattle and is developing product line extensions of its existing products that address mastitis. Its lead product, First Defense, is manufactured from cows' colostrum utilizing its vaccine and milk protein purification technologies.

CEO: Micheal F. Brigham

Teplephone: +1 207 878-2770

Address: 56 Evergreen Drive, Portland 04103, ME, USA

Number of employees: 52

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

81%19%

News

Stocktwits